Industrials / Automation TechnologyTechnical Analysis Guide

EMR Stock Analysis

Emerson Electric Co.

💡 Quick Answer

Across 4 APEX technical signals, EMR is currently split between bullish and bearish readings — 0 bullish, 0 bearish as of 2026-07-08. Run a live analysis to see the current composite score.

EMR has ATR of 2-3% and is in a strategic transformation phase. The market is re-rating it from an industrial conglomerate to an automation technology company.

Process Automation Backlog: LNG + semiconductor demandAspenTech Software: High-margin recurring revenueRSI Behavior: Transformation stock 42-68

Emerson Electric has transformed from a diversified industrial conglomerate into a focused automation technology company following its acquisition of AspenTech and the sale of its climate technologies business. Emerson now operates in process and hybrid automation (process control systems for chemical plants, refineries, and LNG facilities) and discrete automation (factory automation for discrete manufacturers). Its software portfolio. Including AspenTech's simulation and optimization tools. Provides high-margin recurring revenue that is accelerating the company's transition toward a software-defined industrial model.

LIVE CHART·EMR. DailyPowered by TradingView

Open EMR on TradingView ↗Affiliate link

Get live EMR signal analysis

APEX runs 8 signals on EMR in real time: RSI, MACD, Fibonacci, Volume, and more.

Analyze EMR Now →

Why Do Traders Watch EMR?

EMR has ATR of 2-3% and is in a strategic transformation phase. The market is re-rating it from an industrial conglomerate to an automation technology company. Post-earnings moves of 4-7% are typical. EMR benefits from LNG expansion globally (its process control systems are in 80%+ of global LNG plants), semiconductor fab construction (the largest single project type for process automation), and the broader industrial AI/automation buildout.

Is EMR a Buy Right Now? Current Signal Readings

📅Process Automation BacklogLNG + semiconductor demand

Emerson's process automation backlog. Orders from chemical plants, LNG terminals, and semiconductor fabs that haven't yet been delivered. Is the most reliable 2-quarter earnings predictor. Backlog above $8B with book-to-bill ratios above 1.1 signals accelerating demand that will convert to revenue over the next 2-3 quarters.

📊AspenTech SoftwareHigh-margin recurring revenue

AspenTech's process simulation and optimization software generates recurring annual subscription revenue from refineries, chemical companies, and LNG operators. Often embedded in operating processes for 10+ years without switching. AspenTech ARR growth above 10% and annual subscription renewal rates above 95% confirm the software moat is intact and expanding.

📊RSI BehaviorTransformation stock 42-68

EMR's RSI reflects both its industrial cyclicality and its ongoing business transformation. RSI dips to 42-46 during industrial sector selloffs. When LNG and semiconductor fab project pipelines remain strong. Have been reliable entries for traders who track the backlog data to confirm order momentum is independent of broad industrial sentiment swings.

💲Margin ExpansionSoftware mix improvement

Emerson's EBITDA margin has expanded from 18% to 24%+ as its software and recurring services mix has grown. Each percentage point of margin expansion above consensus. Driven by AspenTech integration savings and software subscription growth. Drives incremental analyst estimate raises and PE multiple expansion toward software-peer comparables.

📋 EMR Key Stats for Traders

⚡ATR (14-day)2-3% of price

📦Avg daily volume~3-5 million shares

🎯Key metricProcess automation backlog + AspenTech ARR

📅Post-earnings move4-7% typical

🔗 Related Stocks

HON ROKAMETEKITW

Run a live EMR analysis

APEX combines RSI, MACD, Fibonacci, Volume, and 4 more signals into one composite score in under 30 seconds.

Analyze EMR Free →

Advanced charting for EMR on TradingView ↗

💬 Frequently Asked Questions. EMR

QIs EMR a good stock to buy right now?

AWhether EMR is a buy depends on its current technical positioning. EMR has ATR of 2-3% and is in a strategic transformation phase. The market is re-rating it from an industrial conglomerate to an automation technology company. Post-earnings moves of 4-7% are typical. EMR benefits from LNG expansion globally (its process control systems are in 80%+ of global LNG plants), semiconductor fab construction (the largest single project type for process automation), and the broader industrial AI/automation buildout. Run a live APEX analysis at apexstockintel.com to see the current composite score, RSI, and MACD signals. Updated every trading day.

QWhat are the most important technical signals for EMR?

AThe four key signals for EMR are: Process Automation Backlog (LNG + semiconductor demand). Emerson's process automation backlog. Orders from chemical plants, LNG terminals, and semiconductor fabs that haven't yet been delivered. Is the most reliable 2-quarter earnings predictor. Backlog above $8B with book-to-bill ratios above 1.1 signals accelerating demand that will convert to revenue over the next 2-3 quarters.. AspenTech Software (High-margin recurring revenue). AspenTech's process simulation and optimization software generates recurring annual subscription revenue from refineries, chemical companies, and LNG operators. Often embedded in operating processes for 10+ years without switching. AspenTech ARR growth above 10% and annual subscription renewal rates above 95% confirm the software moat is intact and expanding.. RSI Behavior (Transformation stock 42-68). EMR's RSI reflects both its industrial cyclicality and its ongoing business transformation. RSI dips to 42-46 during industrial sector selloffs. When LNG and semiconductor fab project pipelines remain strong. Have been reliable entries for traders who track the backlog data to confirm order momentum is independent of broad industrial sentiment swings.. Margin Expansion (Software mix improvement). Emerson's EBITDA margin has expanded from 18% to 24%+ as its software and recurring services mix has grown. Each percentage point of margin expansion above consensus. Driven by AspenTech integration savings and software subscription growth. Drives incremental analyst estimate raises and PE multiple expansion toward software-peer comparables.

QWhat is EMR's RSI telling traders right now?

AEMR's RSI reflects both its industrial cyclicality and its ongoing business transformation. RSI dips to 42-46 during industrial sector selloffs. When LNG and semiconductor fab project pipelines remain strong. Have been reliable entries for traders who track the backlog data to confirm order momentum is independent of broad industrial sentiment swings. APEX scores EMR's RSI as part of its 8-factor composite signal. Updated daily.

QHow does EMR behave technically compared to other Industrials / Automation Technology stocks?

AEMR is in the Industrials / Automation Technology sector. Emerson Electric has transformed from a diversified industrial conglomerate into a focused automation technology company following its acquisition of AspenTech and the sale of its climate technologies business. Emerson now operates in process and hybrid automation (process control systems for chemical plants, refineries, and LNG facilities) and discrete automation (factory automation for discrete manufacturers). Its software portfolio. Including AspenTech's simulation and optimization tools. Provides high-margin recurring revenue that is accelerating the company's transition toward a software-defined industrial model. Key stats: ATR (14-day): 2-3% of price, Avg daily volume: ~3-5 million shares, Key metric: Process automation backlog + AspenTech ARR, Post-earnings move: 4-7% typical.

QWhat MACD signals work best for EMR?

AMACD measures momentum direction via the relationship between two exponential moving averages. Bullish crossovers (MACD line crossing above the signal line) indicate increasing upward momentum, while bearish crossovers signal the opposite. APEX tracks EMR's MACD histogram direction daily.

OTHER STOCK GUIDES

Technology49

+−